Identifying the Right CDMO to Support Biopharma Manufacturing
Robert Bloder, Chief Business Officer, Ascendia Pharmaceuticals discusses:
- What to look for when identifying a CDMO for a drug development project
- Ascendia Pharmaceuticals and its expansion of manufacturing services
- Ascendia Pharmaceuticals as a "Partner of Choice"
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Recent Videos
Related Content
